Bagcilar Training & Research Hospital
Istanbul, Turkey (Türkiye)
NCT Number: NCT01310335
The aim of this study is to investigate effect of whole-body vibration on plasma sclerostin level in healthy young adult women.
Fifteen healthy young adult women are planned to include in this study. All cases will be trained on a whole-body vibration (WBV) platform (Power Plate) 5 times a week for one week period. Training duration will be short at the beginning but progressed slowly.
The amplitude of vibration will be 2 mm and the frequency of the vibration will be 40 Hz. The subjects will be asked to report negative side effects or adverse reactions in their training diary.
Previbration and postvibration (just after, 10.minute and 30.minute) levels of plasma sclerostin will be measured on first, second and fifth day of experiment. Sclerostin levels will be measured by human sclerostin ELISA kit.
Looking for future studies?
Notify Me20 year–40 year
Female
Interventional
Not applicable
Istanbul, Turkey (Türkiye)
Whole-body vibration has a strong osteogenic effect. The cyclic mechanical loading to the bone stimulates the osteocytes.
Sclerostin, the protein product of the SOST gene, is an osteocyte-specific cysteine knot-secreted glycoprotein that is a potent inhibitor of bone formation. Sost/sclerostin levels have been reported to be reduced by mechanical stimulation.
The aim of this study is to investigate effect of whole-body vibration on plasma sclerostin level in healthy young adult women.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All cases will be trained on a whole-body vibration (WBV) platform (Power Plate) 5 times a week for one week period.
Other names: Cyclic mechanical loading
Time frame: 1 month
Change of plasma sclerostin level with whole-body vibration
Bagcilar Training and Research Hospital
Other Gov
Effect of Whole-Body Vibration on Plasma Sclerostin Level in Healthy Young Adult Women
Acronym: WBV-SCL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05541432
Behavior, Bone Diseases
Waterloo, Ontario, Canada
View Trial DetailsNCT06988033
Bone Diseases, Bone Diseases, Metabolic
Istanbul, Uskudar, Turkey (Türkiye)
View Trial DetailsNCT06813092
Behavior, Bone Diseases
Erlangen, Germany
View Trial DetailsNCT03483584
Avitaminosis, Bone Diseases
Shatin, Hong Kong
View Trial Details